These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 29946047)

  • 21. Lower prevalence of hlyD, papC and cnf-1 genes in ciprofloxacin-resistant uropathogenic Escherichia coli than their susceptible counterparts isolated from southern India.
    Harwalkar A; Gupta S; Rao A; Srinivasa H
    J Infect Public Health; 2014; 7(5):413-9. PubMed ID: 24861644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distribution of virulence genes and phylogenetics of uropathogenic Escherichia coli among urinary tract infection patients in Addis Ababa, Ethiopia.
    Dadi BR; Abebe T; Zhang L; Mihret A; Abebe W; Amogne W
    BMC Infect Dis; 2020 Feb; 20(1):108. PubMed ID: 32033541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intranasal immunization with fusion protein MrpH·FimH and MPL adjuvant confers protection against urinary tract infections caused by uropathogenic Escherichia coli and Proteus mirabilis.
    Habibi M; Asadi Karam MR; Shokrgozar MA; Oloomi M; Jafari A; Bouzari S
    Mol Immunol; 2015 Apr; 64(2):285-94. PubMed ID: 25562574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipopolysaccharide Domains Modulate Urovirulence.
    Aguiniga LM; Yaggie RE; Schaeffer AJ; Klumpp DJ
    Infect Immun; 2016 Nov; 84(11):3131-3140. PubMed ID: 27528276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cloaking antibodies are prevalent in
    Pham A; Tan KKY; Ledger EL; Smith DJ; Reid DW; Burr L; Chambers DC; Wells TJ
    Front Cell Infect Microbiol; 2024; 14():1426773. PubMed ID: 39193503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Virulence factors of uropathogenic E. coli and their interaction with the host.
    Lüthje P; Brauner A
    Adv Microb Physiol; 2014; 65():337-72. PubMed ID: 25476769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dysregulation of Escherichia coli α-hemolysin expression alters the course of acute and persistent urinary tract infection.
    Nagamatsu K; Hannan TJ; Guest RL; Kostakioti M; Hadjifrangiskou M; Binkley J; Dodson K; Raivio TL; Hultgren SJ
    Proc Natl Acad Sci U S A; 2015 Feb; 112(8):E871-80. PubMed ID: 25675528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunization with recombinant protein Ag43::UpaH with alum and 1,25(OH)2D3 adjuvants significantly protects Balb/C mice against urinary tract infection caused by uropathogenic Escherichia coli.
    Habibi M; Azimi S; Khoobbakht D; Roghanian P; Asadi Karam MR
    Int Immunopharmacol; 2021 Jul; 96():107638. PubMed ID: 33848909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteomic analysis of uropathogenic Escherichia coli.
    Cash P
    Expert Rev Proteomics; 2014 Feb; 11(1):43-58. PubMed ID: 24393038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intramacrophage survival of uropathogenic Escherichia coli: differences between diverse clinical isolates and between mouse and human macrophages.
    Bokil NJ; Totsika M; Carey AJ; Stacey KJ; Hancock V; Saunders BM; Ravasi T; Ulett GC; Schembri MA; Sweet MJ
    Immunobiology; 2011 Nov; 216(11):1164-71. PubMed ID: 21802164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Whole-genome sequencing of uropathogenic Escherichia coli reveals long evolutionary history of diversity and virulence.
    Lo Y; Zhang L; Foxman B; Zöllner S
    Infect Genet Evol; 2015 Aug; 34():244-50. PubMed ID: 26112070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Uropathogenic Escherichia coli are less likely than paired fecal E. coli to have CRISPR loci.
    Dang TN; Zhang L; Zöllner S; Srinivasan U; Abbas K; Marrs CF; Foxman B
    Infect Genet Evol; 2013 Oct; 19():212-8. PubMed ID: 23891665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. UPEC strain characterization isolated from Mexican patients with recurrent urinary infections.
    Morales-Espinosa R; Hernandez-Castro R; Delgado G; Mendez JL; Navarro A; Manjarrez A; Cravioto A
    J Infect Dev Ctries; 2016 Apr; 10(4):317-28. PubMed ID: 27130992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular characterisation of uropathogenic
    Chakraborty A; Adhikari P; Shenoy S; Saralaya V
    Indian J Med Microbiol; 2017; 35(2):305-310. PubMed ID: 28681829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phylogenetic group distributions, virulence factors and antimicrobial resistance properties of uropathogenic Escherichia coli strains isolated from patients with urinary tract infections in South Korea.
    Lee JH; Subhadra B; Son YJ; Kim DH; Park HS; Kim JM; Koo SH; Oh MH; Kim HJ; Choi CH
    Lett Appl Microbiol; 2016 Jan; 62(1):84-90. PubMed ID: 26518617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Virulence behavior of uropathogenic Escherichia coli strains in the host model Caenorhabditis elegans.
    Schifano E; Marazzato M; Ammendolia MG; Zanni E; Ricci M; Comanducci A; Goldoni P; Conte MP; Uccelletti D; Longhi C
    Microbiologyopen; 2019 Jun; 8(6):e00756. PubMed ID: 30381890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Virulence factors and O groups of Escherichia coli strains isolated from cultures of blood specimens from urosepsis and non-urosepsis patients.
    Blanco M; Blanco JE; Alonso MP; Blanco J
    Microbiologia; 1994 Sep; 10(3):249-56. PubMed ID: 7532950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibiotic resistance, virulence factors and genotyping of Uropathogenic
    Raeispour M; Ranjbar R
    Antimicrob Resist Infect Control; 2018; 7():118. PubMed ID: 30305891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uropathogenic
    Stocks CJ; Phan MD; Achard MES; Nhu NTK; Condon ND; Gawthorne JA; Lo AW; Peters KM; McEwan AG; Kapetanovic R; Schembri MA; Sweet MJ
    Proc Natl Acad Sci U S A; 2019 Mar; 116(13):6341-6350. PubMed ID: 30846555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uropathogenic Escherichia coli virulence and innate immune responses during urinary tract infection.
    Ulett GC; Totsika M; Schaale K; Carey AJ; Sweet MJ; Schembri MA
    Curr Opin Microbiol; 2013 Feb; 16(1):100-7. PubMed ID: 23403118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.